Testing COVID-19 or pneumonia treatments in hospitalized patients
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial tests different treatments for serious lung infections in people who are already in the hospital. It may help doctors learn which treatment works best for recovery and survival when pneumonia-like illness is suspected.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently hospitalized
- Doctors think you have pneumonia or pneumonia-like lung disease
- The cause is one of these: confirmed influenza A/B (possibly with COVID-19) or community-acquired pneumonia needing antibiotics
- Doctors believe other causes (like heart failure) are unlikely
- There is no major medical condition that would make joining too risky, in the clinician’s opinion
- You are not being treated mainly for certain other infections like tuberculosis or PCP (a specific lung fungal infection)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows how community-acquired pneumonia progresses in hospitalized patients who already have serious health problems or weakened immune systems. The goal is to better understand risk and changes over time, which may help guide future care for people like you.
This study follows people who are admitted to a respiratory intensive care unit (a special ICU for breathing problems) because they have pneumonia. It may help doctors better understand pneumonia in ICU patients and improve care in the future.
This study tests ways to improve treatment for adults with severe pneumonia that lands them in the ICU, adjusting the plan as results come in. It may help your care team find better treatments for lung infection and breathing/heart support needs.
This trial tests a way to give antibiotics directly to the lungs (inhaled or nebulized) for people hospitalized with moderate to severe pneumonia. The goal is to see if this local treatment works better than standard antibiotics alone and helps you recover faster.
This trial studies whether giving antibiotics affects recovery in adults hospitalized with moderately severe infections caused by specific viruses (influenza, parainfluenza, RSV, or hMPV). It may help show when antibiotics are helpful or unnecessary for viral airway illness.
This study looks at how hospital-acquired pneumonia is diagnosed and treated in China. If you join, your doctors will track your infection and treatment to help improve care for future patients.
Hear when a new Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.